APH vs DYN · P/E 40, rev $23.09B vs $1.19B cap
Amphenol Corporation (APH) versus Dyne Therapeutics Inc (DYN) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
DYN does not have a complete income-statement cache yet.
APH currently screens at market cap $170.77B and trailing P/E 39.9. DYN currently screens at market cap $1.19B.
Not investment advice. Open the APH and DYN stock pages for the full models.
Not investment advice.